The US dental membrane and bone graft substitute market is projected to reach US$ 12,769.00 million by 2028 from US$ 6,824.56 million in 2022; it is estimated to grow at a CAGR of 11.4% from 2023 to 2028.
Dental membranes are barrier membranes used for guided tissue regeneration (GTR) and guided bone regeneration (GBR). Their functions are to provide biosafety, biocompatibility, and appropriate mechanical properties. Constant research and development have enabled to launch of various novel membranes in the market. For dental procedures, bone grafts are used for facial trauma treatment, tooth extractions, dental implant placement, and reconstructive mouth, face, and jaw surgery. At the same time, bone graft substitutes are made from natural or synthetic materials that contain only mineralized bone matrix with no viable cells. The US dental membrane and bone graft substitute market is driven by a few key driving factors, such as the increasing burden of periodontal diseases and oral cancer and an increase in demand for dental cosmetic procedures. However, the market growth is hindered by limitations and misconceptions associated with of reimbursement policies.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
US Dental Membrane and Bone Graft Substitute Market: Strategic Insights
US Dental Membrane and Bone Graft Substitute Market
-
Market Size 2022
US$ 6,824.56 Million
-
Market Size 2028
US$ 12,769.00 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Regional Overview
- United State
Market Segmentation
Type
- Dental Bone Graft Substitutes
- Dental Barrier Membrane
- Grafting Procedure
- Dental Soft Tissue Regeneration
Procedure
- Dental Barrier Membrane and Grafting Procedures
End User
- Hospitals
- Dental Clinics
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
US Dental Membrane and Bone Graft Substitute MarketReport ScopeUS Dental Membrane and Bone Graft Substitute Market Report Scope
Report Attribute
Details
Market size in 2022
US$ 6,824.56 Million
Market Size by 2028
US$ 12,769.00 Million
Global CAGR (2023 - 2028)
11.4%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Type - Dental Bone Graft Substitutes
- Dental Barrier Membrane
- Grafting Procedure
- Dental Soft Tissue Regeneration
By Procedure - Dental Barrier Membrane and Grafting Procedures
By End User - Hospitals
- Dental Clinics
Regions and Countries Covered
United State- United State
Market leaders and key company profiles
Dentsply Sirona Inc
Dentium Co Ltd
Geistlich Pharma AG
ZimVie Inc
Keystone Dental Inc
Straumann Holding AG
Medtronic Plc
BioHorizons Inc
MEDOSIS
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
US Dental Membrane and Bone Graft Substitute Market: Strategic Insights
-
Market Size 2022
US$ 6,824.56 Million -
Market Size 2028
US$ 12,769.00 Million
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Regional Overview
- United State
Market Segmentation
Type - Dental Bone Graft Substitutes
- Dental Barrier Membrane
- Grafting Procedure
- Dental Soft Tissue Regeneration
Procedure - Dental Barrier Membrane and Grafting Procedures
End User - Hospitals
- Dental Clinics
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
US Dental Membrane and Bone Graft Substitute Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 6,824.56 Million |
| Market Size by 2028 | US$ 12,769.00 Million |
| Global CAGR (2023 - 2028) | 11.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | United State
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Procedure, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The US dental membrane and bone graft substitute market in the United States is growing due to increasing incidences of periodontal diseases and oral cancer, and growing demand of cosmetic dentistry in the country. In the US, a national health interview survey has reported a high prevalence of periodontitis based on oral health assessments; the prevalence of periodontitis among adults older than 30 is estimated at ~47%, rising to 70% in those aged 65 and above. The prevalence of moderate and severe periodontitis, which is more closely associated with systemic inflammation and the immune response, is very high in adults over 65. Periodontal disease can lead to resorption and failure of the alveolar bone, loss of periodontal attachment, and loosening & falling of the teeth. Therefore, treatment of periodontal disease focuses on eliminating the source of infection, stimulating factors, and pays attention to repairing periodontal tissue defects and restoring normal morphology & function. Bone grafting is done for repairing periodontal defects by grafting materials (bone or bone substitutes) to restore the anatomical morphology of the alveolar bone and the function of the periodontal tissue. Therefore, the growing cases of periodontal diseases and oral cancer contribute to the growth of the US dental membrane and bone graft market. Also, according to the American Academy of Cosmetic Dentistry, the US alone spent ~US$ 2.75 billion annually on cosmetic dentistry in 2021. According to the Cosmetic Dentistry: State of the Industry Report, an average patient spent US$ 4,336 on cosmetic dentistry in 2019 in the US. Therefore, an upsurge in demand for cosmetic dentistry is favoring the dental membrane and bone graft substitute market.
The US dental membrane and bone graft substitute market majorly consists of players such as Dentsply Sirona Inc, Dentium Co Ltd, Geistlich Pharma AG, ZimVie Inc, Keystone Dental Inc, Straumann Holding AG, Medtronic Plc, BioHorizons Inc, MEDOSIS, and LifeNet Health Inc. among others.
Dental membranes are barrier membranes used for two procedures: guided tissue regeneration (GTR) and guided bone regeneration (GBR). The functions of the membranes are to provide biosafety, biocompatibility, and appropriate mechanical properties. Also, a dental membrane needs to be bioactive to promote tissue regeneration. Various commercially available membranes are on the market, and constant research and development for novel membranes are conducted to introduce new ones. For dental procedures, bone grafts are used for facial trauma treatment, tooth extractions, dental implant placement, and reconstructive mouth, face, and jaw surgery. Bone graft substitutes are natural or synthetic materials often containing only mineralized bone matrix with no viable cells.
Key factors such as increasing burden of periodontal diseases and oral cancer and increase in demand for dental cosmetic procedures are expected to boost the market growth for the US dental membrane and bone graft substitute over the years.
The grafting procedures segment dominated the US dental membrane and bone graft substitute market and held the largest revenue share of 85.65% in 2022.
The grafting procedures segment dominated the US dental membrane and bone graft substitute market and held the largest revenue share of 85.65% in 2022.
The dental clinics segment dominated the US dental membrane and bone graft substitute market and accounted for the largest revenue share of 61.63% in 2022.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - US Dental Membrane and Bone Graft Substitute Market
- Dentsply Sirona Inc
- Dentium Co Ltd
- Geistlich Pharma AG
- ZimVie Inc
- Keystone Dental Inc
- Straumann Holding AG
- Medtronic Plc
- BioHorizons Inc
- MEDOSIS
- LifeNet Health Inc
Get Free Sample For